OSTEOMYELITIS AND BONE-MARROW APLASIA AFTER GASTROSCOPY

被引:0
|
作者
SCHUSTER, S
BORNER, N
WEILEMANN, LS
MEYER, J
机构
关键词
ESCHERICHIA-COLI SEPSIS; BONE-MARROW APLASIA; OSTEOMYELITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe bleedings and infections following gastroscopy may lead to life threatening complications. A 56-year-old patient underwent a Billroth-II gastrectomy because of gastric cancer. Following endoscopic removal of a biopsy acute upper gastrointestinal bleeding occurred which ceased after administration of fresh-frozen plasma and >>prothrombin complex<<. The following day she developed a septic shock with disseminated intravascular coagulation and neurological symptoms. In the bone marrow aspirate Escherichia coli could be identified. The radionuclide bone- and marrow scan revealed a generalized osteomyelitis and an extensive extramedullary hematopoiesis. High-dose triple antibiotic therapy provided temporary relief of the clinical symptoms. Four weeks later she developed multiple fractures of the thoracic vertebral bodies, ilium and ischium. A type-IV bone-marrow aplasia developed with insufficient hematopoiesis. The patient died as a result of the osteomyelitis and aplasia. Bacteriological examination of the gastric contents was not performed in order to proof the focus. The short-time interval relating to the bleeding event, the E. coli sepsis and no evidence for another cause of the bacteremia makes the biopsy as the original focus more likely. Consequently, antibiotic prophylaxis should be administered in high-risk patients with valvular heart disease and should also be considered in patients with compromised defense.
引用
收藏
页码:160 / 163
页数:4
相关论文
共 50 条
  • [41] THE LONG-TERM FATE OF BONE-MARROW APLASIA
    BAUMELOU, E
    GUERIN, MN
    REVUE DU PRATICIEN, 1981, 31 (47): : 3365 - &
  • [42] FATAL BONE-MARROW APLASIA DUE TO CHLORAMPHENICOL IN A BABY
    WHITE, MP
    HABBOUSH, HW
    ALROOMI, LG
    LANCET, 1986, 1 (8480): : 555 - 556
  • [43] THE TRIALS OF IMMUNOSUPPRESSIVE THERAPY IN BONE-MARROW APLASIA TODAY
    GLUCKMAN, E
    DEVERGIE, A
    REVUE DU PRATICIEN, 1981, 31 (47): : 3355 - &
  • [44] BONE-MARROW TRANSPLANTATION BEYOND TREATMENT OF APLASIA AND NEOPLASIA
    BEUTLER, E
    WESTERN JOURNAL OF MEDICINE, 1994, 160 (02): : 129 - 132
  • [45] FATAL BONE-MARROW APLASIA COMPLICATING PROCHLORPERAZINE THERAPY
    BHASKARAN, K
    SUBRAHMA.P
    NAND, DS
    AMERICAN JOURNAL OF PSYCHIATRY, 1962, 119 (04): : 373 - &
  • [46] SUPPORTIVE CARE FOR LEUKEMIA PATIENTS IN BONE-MARROW APLASIA
    REES, JKH
    HAYHOE, FGJ
    LANCET, 1981, 2 (8258): : 1282 - 1282
  • [47] PROBLEMS RAISED BY THE CLINICAL DEFINITION OF BONE-MARROW APLASIA
    NAJEAN, Y
    REVUE DU PRATICIEN, 1981, 31 (47): : 3335 - 3336
  • [48] ABNORMAL MIXED LEUKOCYTE REACTION IN BONE-MARROW APLASIA
    SASPORTES, M
    BERNARD, A
    DAUSSET, J
    BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5883): : 48 - 49
  • [49] THE PROGNOSIS OF BONE-MARROW APLASIA AND ITS RELATIONSHIP WITH THE MANAGEMENT
    MUSSO, AM
    SANTOS, MI
    MARIN, CA
    ESPINOLA, RG
    PRENSA MEDICA ARGENTINA, 1987, 74 (01): : 17 - 22
  • [50] REVERSIBLE CAPTOPRIL-ASSOCIATED BONE-MARROW APLASIA
    STRAIR, RK
    MITCH, WE
    FALLER, DV
    SKORECKI, KL
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (04) : 320 - 322